Xtant Medical to Present at the H.C. Wainwright BioConnect Virtual Conference

Rhea-AI Summary

Xtant Medical Holdings, a global medical technology company specializing in spinal disorder solutions, announced that CEO Sean Browne will present at the H.C. Wainwright BioConnect Virtual Conference from January 10-13, 2022. A pre-recorded presentation will be available on the company's website starting January 10, 2022, at 7:00 AM Eastern Time and will remain accessible for 30 days. Xtant focuses on designing and commercializing orthobiologics and spinal implant systems for complex spinal procedures.

News Market Reaction – XTNT

+4.51%

+4.51% Session move

In the trading session that priced this news, XTNT gained 4.51%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BELGRADE, Mont., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, Chief Executive Officer, will present at the H.C. Wainwright BioConnect Virtual Conference taking place January 10-13, 2022.

A pre-recorded presentation will be available on the Investors section of the Company’s website at www.xtantmedical.com, beginning on Monday, January 10, 2022, at 7:00 AM Eastern Time. The presentation will be accessible for 30 days.

About Xtant Medical Holdings, Inc.

Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.

The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.

Investor Relations Contact

David Carey
Lazar FINN
Ph: 212-867-1762
Email: david.carey@finnpartners.com

FAQ

When will Xtant Medical's CEO present at the BioConnect Virtual Conference?

Sean Browne, CEO of Xtant Medical, will present at the H.C. Wainwright BioConnect Virtual Conference from January 10-13, 2022.

Where can I find Xtant Medical's presentation from the BioConnect Virtual Conference?

The pre-recorded presentation will be available on Xtant Medical's website starting January 10, 2022, at 7:00 AM Eastern Time.

How long will Xtant Medical's presentation be available online?

The presentation will be accessible for 30 days starting from January 10, 2022.

What is Xtant Medical known for?

Xtant Medical is known for its focus on surgical solutions for spinal disorders, including the design and commercialization of orthobiologics and spinal implant systems.